Annual ROE:
-37.40%-23.39%(-166.95%)Summary
- As of today, DNLI annual return on equity is -37.40%, with the most recent change of -23.39% (-166.95%) on December 31, 2024.
- During the last 3 years, DNLI annual ROE has fallen by -9.89% (-35.95%).
- DNLI annual ROE is now -506.08% below its all-time high of 9.21%, reached on December 31, 2020.
Performance
DNLI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-39.36%-4.51%(-12.94%)Summary
- As of today, DNLI quarterly return on equity is -39.36%, with the most recent change of -4.51% (-12.94%) on June 30, 2025.
- Over the past year, DNLI quarterly ROE has dropped by -5.40% (-15.90%).
- DNLI quarterly ROE is now -484.75% below its all-time high of 10.23%, reached on December 31, 2020.
Performance
DNLI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DNLI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -166.9% | -15.9% |
| 3Y3 Years | -36.0% | -34.5% |
| 5Y5 Years | +10.9% | +14.1% |
DNLI ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -166.9% | at low | -230.2% | +1.8% |
| 5Y | 5-Year | -506.1% | +10.9% | -484.8% | +4.5% |
| All-Time | All-Time | -506.1% | +38.0% | -484.8% | +14.1% |
DNLI ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -39.36%(-12.9%) |
| Mar 2025 | - | -34.85%(-5.9%) |
| Dec 2024 | -37.40%(-167.0%) | -32.92%(+2.8%) |
| Sep 2024 | - | -33.87%(+0.3%) |
| Jun 2024 | - | -33.96%(-184.9%) |
| Mar 2024 | - | -11.92%(+12.2%) |
| Dec 2023 | -14.01%(+56.9%) | -13.58%(-11.9%) |
| Sep 2023 | - | -12.14%(+7.5%) |
| Jun 2023 | - | -13.12%(+67.3%) |
| Mar 2023 | - | -40.08%(-13.6%) |
| Dec 2022 | -32.52%(-18.2%) | -35.29%(-7.0%) |
| Sep 2022 | - | -32.97%(-12.6%) |
| Jun 2022 | - | -29.27%(-3.9%) |
| Mar 2022 | - | -28.18%(-2.8%) |
| Dec 2021 | -27.51%(-398.7%) | -27.40%(-1068.2%) |
| Sep 2021 | - | 2.83%(-52.3%) |
| Jun 2021 | - | 5.93%(-14.2%) |
| Mar 2021 | - | 6.91%(-32.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | 9.21%(+121.9%) | 10.23%(+124.8%) |
| Sep 2020 | - | -41.22%(+10.0%) |
| Jun 2020 | - | -45.80%(-0.8%) |
| Mar 2020 | - | -45.44%(-9.1%) |
| Dec 2019 | -41.97%(-486.2%) | -41.66%(-207.5%) |
| Sep 2019 | - | -13.55%(-22.3%) |
| Jun 2019 | - | -11.08%(-9.8%) |
| Mar 2019 | - | -10.09%(-39.4%) |
| Dec 2018 | -7.16%(+70.8%) | -7.24%(+77.2%) |
| Sep 2018 | - | -31.79%(-9.0%) |
| Jun 2018 | - | -29.17%(-28.7%) |
| Mar 2018 | - | -22.67%(+21.7%) |
| Dec 2017 | -24.49%(+59.4%) | -28.96%(+23.4%) |
| Sep 2017 | - | -37.82%(-3.1%) |
| Jun 2017 | - | -36.70%(-31.0%) |
| Mar 2017 | - | -28.01%(-42.7%) |
| Dec 2016 | -60.34%(-17.4%) | -19.63% |
| Dec 2015 | -51.38% | - |
FAQ
- What is Denali Therapeutics Inc. annual return on equity?
- What is the all-time high annual ROE for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual ROE year-on-year change?
- What is Denali Therapeutics Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly ROE year-on-year change?
What is Denali Therapeutics Inc. annual return on equity?
The current annual ROE of DNLI is -37.40%
What is the all-time high annual ROE for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual return on equity is 9.21%
What is Denali Therapeutics Inc. annual ROE year-on-year change?
Over the past year, DNLI annual return on equity has changed by -23.39% (-166.95%)
What is Denali Therapeutics Inc. quarterly return on equity?
The current quarterly ROE of DNLI is -39.36%
What is the all-time high quarterly ROE for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly return on equity is 10.23%
What is Denali Therapeutics Inc. quarterly ROE year-on-year change?
Over the past year, DNLI quarterly return on equity has changed by -5.40% (-15.90%)